ALX Oncology Earning Date (ALXO)

USA |NASDAQ |USD

ALXO Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 10, 2022 Jun 2022 - - $-0.40
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 10, 2022 Jun 2022 - - $0.00

Alx Oncology's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 2022.

ALXO Earnings Date & History Chart

ALXO Earnings & Revenue Forecast

ALXO Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $-2.55 $-3.25 $-2.21

ALXO Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 3 $-2.37 $-2.34 $-2.25

ALXO Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $520.00K $0.00 $2.60M

ALXO Earnings Date & Revenue History

ALXO Earnings History

|
Show More
Show More

ALXO Revenue History

|
Show More
Show More

Alx Oncology Next Earnings Date & Report

ALXO Next Earnings Date & Report Preview: Jun 2022 (FQ)

ALXO's next earnings date is Wednesday, Aug 10, 2022 for the fiscal quarter ending Jun 30, 2022.

Alx Oncology Previous Earnings Dates & Reports

ALXO Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Alx Oncology's previous earnings date was May 16, 2022 for its fiscal quarter ended Mar 31, 2022.

ALXO Previous Earnings Date & Report Recap: Dec 2021 (FY)

Alx Oncology's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

ALXO's earnings per share (EPS) was $-2.06, missing the consensus analysts forecast of $-1.88 by 9.57% , and higher than the previous year's EPS (Dec 2020) by -60.38%.

Revenues were $0.00.

The company reported a net income of $-83.50M.

Alx Oncology reported a free cash flow of $-68.77M for its fiscal year, compared to $-38.32M a year ago.